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About 10% of all protein kinases are predicted to be
enzymatically inactive pseudokinases, but the struc-
tural details of kinase inactivation have remained
unclear. We present the first structure of a pseudoki-
nase, VRK3, and that of its closest active relative,
VRK2. Profound changes to the active site region
underlie the loss of catalytic activity, and VRK3
cannot bind ATP because of residue substitutions in
the binding pocket. However, VRK3 still shares
striking structural similarity with VRK2, and appears
to be locked in a pseudoactive conformation. VRK3
also conserves residue interactions that are
surprising in theabsenceof enzymatic function; these
appear to play important architectural roles required
for the residual functions of VRK3. Remarkably,
VRK3 has an ‘‘inverted’’ pattern of sequence conser-
vation: although the active site is poorly conserved,
portions of the molecular surface show very high
conservation, suggesting that they form key interac-
tions that explain the evolutionary retention of VRK3.
INTRODUCTION
Protein kinases modulate the activity of most cellular processes
by phosphorylation of substrate proteins, leading to changes in
activity, localization, and turnover (Hunter, 2000). However, 49
human protein kinase domains are predicted to be enzymatically
inactive (pseudokinases), owing to the lack of essential catalytic
residues (Manning et al., 2002b). Many pseudokinases are
conserved throughout metazoans (Caenepeel et al., 2004;
Manning et al., 2002a), indicating that their kinase domains retain
essential functions. Known pseudokinase domain functions
include coreceptors (ErbB3, EphA10, EphB6, CCK4), regulators
of a second active kinase domain in the same protein (the pseu-
dokinase domains of JAKs and GCN2), guanylate cyclases, and
scaffolding proteins (STRAD, ILK, KSR, TRRAP, Trb3) (reviewed
in Boudeau et al. [2006]). Several pseudokinases have been
implicated in cancer and other diseases (Manning and Caene-128 Structure 17, 128–138, January 14, 2009 ª2009 Elsevier Ltd Allpeel, 2006). A few kinases have been shown to retain activity
even after loss of key functional residues, including the WNK
family and Titin; their structures have revealed compensatory
changes that maintain catalytic function (Mayans et al., 1998;
Min et al., 2004). Remarkably, CASK, which was initially predicted
to be a pseudokinase based on loss of a key motif (Manning et al.,
2002b), was recently shown through structural and biochemical
analysis to bind ATP and retain catalytic activity (Mukherjee
et al., 2008). However, no ‘‘genuine’’ pseudokinase structure,
which truly lacks catalytic activity, has been described to date.
VRK3 is a pseudokinase member of the vaccinia related
kinase (VRK) family, which also includes two active vertebrate
paralogs (VRK1 and VRK2), one or two orthologs in all meta-
zoans, and an ortholog in most poxviruses, including the found-
ing member, vaccinia virus B1R (Boyle and Traktman, 2004;
Manning et al., 2002a, 2002b; Nezu et al., 1997; Nichols and
Traktman, 2004; Vega et al., 2003). The VRK family is part of
the CK1 kinase group, which displays distinctive alterations to
some motifs conserved in almost all other kinases, but still
assumes the standard kinase fold (Scheeff and Bourne, 2005).
VRK1 is an active nuclear kinase whose substrates include
p53, ATF, Jun, BAF, and histone H3, and is involved in cell cycle,
chromatin condensation, and transcriptional regulation (Kang
et al., 2007; Lopez-Borges and Lazo, 2000; Nichols and Trakt-
man, 2004; Nichols et al., 2006; Sevilla et al., 2004; Valbuena
et al., 2007, 2008; Vega et al., 2004). VRK2 also phosphorylates
p53 and BAF (Blanco et al., 2006; Nichols et al., 2006). VRK2 has
two splice forms that localize either to the nucleus and cyto-
plasm or to the ER and mitochondria (Blanco et al., 2006). The
alternatively spliced C-terminal tail interacts with and regulates
several components of the JNK signalosome (JIP-1, TAK1, and
MKK7), and with BHRF1, an Epstein-Barr virus homolog of
Bcl-2, independent of kinase activity (Blanco et al., 2007, 2008;
Li et al., 2006).
VRK3 is the only VRK to lack enzymatic activity (Nichols and
Traktman, 2004), but it is known to inhibit Erk signaling by
binding and activating the Erk phosphatase, VHR (Kang and
Kim, 2006, 2008). VRK3 is in turn transcriptionally induced by
Erk (Kang and Kim, 2006).
We present here the crystal structure of the VRK3 kinase
domain, the first solved pseudokinase, along with that of its active
paralog, VRK2. We examine the changes that have occurred inrights reserved
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Structure of the Pseudokinase VRK3VRK3 upon loss of catalytic activity, and the implications of these
changes for its remaining functions. We also describe shifts in
conservation patterns in VRK3 that suggest a location for
a protein binding site, perhaps that of VHR. Finally, we examine
the implications of the VRK3 structure for the many pseudoki-
nases for which only sequence information is available.
RESULTS
VRK3 and VRK2 Are Structurally Very Similar
The catalytic domain structures of VRK3 (residues 148–472) and
VRK2 (residues 15–330) reveal the typical protein kinase fold
(Figure 1; see Table S1 available online for crystallographic data).
We name elements in the fold according to standard convention,
which is based on protein kinase A (PKA) (Bossemeyer et al.,
1993). VRK3 is well structured, with only a short loop between
b2 and b3 (residues 188–197) not defined by electron density
and assumed to be disordered. VRK2 is also well structured,
except for the ATP-binding glycine-rich loop (G-loop, G36-G41)
and N67 in the loop linking b3 to aC. The unstructured G-loop is
commonly seen in kinase structures without bound ATP. In con-
trast, the VRK3 G-loop is well ordered, with low B-values that indi-
cate that it is rigid in the absence of ATP. Both kinase structures
are in an active conformation (Huse and Kuriyan, 2002): the two
lobes of the kinase domain are closed, aC is rotated inwards,
and a key ion pair between K72-E91PKA is formed. Further, a
hydrophobic spine that stabilizes the active conformation (Kor-
nev et al., 2006) is assembled in both structures. Finally, the acti-
vation segments of both structures are in conformations compat-
ible with activity (Huse and Kuriyan, 2002; Nolen et al., 2004), and
also have low B-values, indicating that they are more rigid than in
most kinases. This is consistent with rigid activation segments
seen in other CK1-group kinases (Nolen et al., 2004).
The overall structures of VRK3 and VRK2 are similar and
superimpose with an RMSD of 2.3 A˚, using 291 main-chain posi-
Figure 1. Superimposition of the Kinase
Domain Structures of VRK3 (blue) and
VRK2 (red)
(Inset) Magnified view of highly conserved resi-
dues linking aC4 to aE.
tions (Figure 1; see Table S2). Both VRK2
and VRK3 have nearly identical levels
of structural similarity to other protein
kinases, indicating that the loss of activity
in VRK3 has not lead to any major struc-
tural change (Table S2). This contrasts
greatly to expectations based on
sequence alignment: although VRK1 and
VRK2 share 56% sequence identity,
similar to many vertebrate paralogs,
VRK3 is only 38% identical to VRK2, and
was previously predicted to be a pseudo-
kinase of degraded structure (Manning
et al., 2002b).
Still, there are a number of small differ-
ences in secondary structure. In the
C-terminal lobe, two helices are shortened in VRK2 relative to
VRK3 and CK1: aD is truncated, containing only a half a helical
turn, and aI is shortened and loses its distinctive kink (Scheeff
and Bourne, 2005). Conversely, VRK3 has a b-hairpin linking
aG and aH in place of the short helix seen in VRK2 and CK1.
This region is often important in substrate recognition (Bosse-
meyer et al., 1993; Huse and Kuriyan, 2002), and its modification
in VRK3 might reflect its catalytic inactivity.
The most striking unique feature of the VRK structures is an
additional helix (aC4) between aC and b4 that anchors aC to
the C-terminal lobe (Figure 1). A similar insert is found in the
sequences of all VRK family members (Figure S1). Two highly
conserved positions in aC4 pack against aE: a conserved hydro-
phobic residue at V227VRK3 and an aromatic residue at
W230VRK3. Both residues interact with a highly conserved F/Y
residue at F296VRK3 in helix aE to form the center of a small
hydrophobic core linking the two helices (Figure 1). The tight
link between aC4 and aE extends the contact region between
the two lobes of the kinase, likely inducing the catalytic domain
to remain in an active closed conformation (Huse and Kuriyan,
2002) and suggesting that all VRKs are constitutively active.
This is supported by the lack of a conserved activation loop
phosphorylation site or hrD arginine in VRKs (see below;
Figure S1). The only other kinases with a known helix insert in
this region are SRPKs, but that helix has a very different orienta-
tion (Nolen et al., 2001), and the SRPKs are not close relatives of
the VRKs (Manning et al., 2002b). Although the SRPK helix
appears to be an independent invention, it has been proposed
to have a similar function (Nolen et al., 2001).
VRK3 Contains Multiple Sequence Changes that Lead
to Inactivity
Although the overall fold of VRK3 is intact and similar to VRK2,
disruptions to several key motifs render it catalytically inert.
The motifs required for kinase catalytic activity have beenStructure 17, 128–138, January 14, 2009 ª2009 Elsevier Ltd All rights reserved 129
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Structure of the Pseudokinase VRK3extensively characterized (Hanks and Hunter, 1995; Kannan
et al., 2007; Scheeff and Bourne, 2005) and include a glycine-
rich G-loop, a lysine-glutamate ion pair at K72-E91PKA, a catalytic
loop (hrDxkxxN), and a metal-binding motif (DfG). Some of these
motifs are severely degraded in all vertebrate VRK3 orthologs,
indicating that the loss of activity occurred early in the evolution
of VRK3 (Figure 2A, Figure S1). Here, we systematically examine
changes in the catalytic motifs within VRK3, in both a structural
and evolutionary context.
The ATP Binding Site of VRK3 Is Highly Degraded
The protein kinase G-loop (GxGxfG motif) positions ATP for effi-
cient catalysis by interacting with its phosphate groups. The
glycines provide conformational flexibility, enabling hydrogen-
bond formation between the backbone of the loop and the g-
phosphate of ATP (Madhusudan et al., 2002). The lack of side
chains in glycine also prevents steric clashes with ATP (Bosse-
meyer, 1994). The loop motif is highly degraded in all VRK3 or-
thologs, with the glycines often replaced by substantially larger
residues (Figures 2A and 2B). We modeled ATP in the VRK3
structure by superimposing the ATP-bound form of CK1, which
is the closest relative of the VRKs (Table S2), and has a highly
similar loop motif (Figure 2A). This revealed several distinct
Figure 2. The Altered Active Site Region
of VRK3
(A) Sequence conservation logos for key motifs in
VRK3s, active VRKs, and the CK1 family, based on
appropriate subsets of a curated sequence/struc-
ture alignment of diverse homologs (see methods).
Standard motifs seen across protein kinases are
shown below the logo representation (uppercase
residues are conserved nearly to identity across
all protein kinases, whereas lowercase residues
are partially conserved; x indicates any residue;
o, hydrophobic). Numbered VRK3 residues are
shown in panels B and C. Yellow diamonds high-
light positions in which the VRK3s violate evolu-
tionary constraints seen in active VRKs and CK1s.
(B) Comparison of the ATP binding pockets of CK1
and VRK3. ATP from the CK1 structure is modeled
into VRK3 based on structural superimposition.
Yellow marks VRK3 residue positions that violate
evolutionary constraints (as per panel A), whereas
white marks other residues with relevant contacts.
Homologous CK1 residues are colored identically
to VRK3 residues. Hydrogen bonds are shown as
green dotted lines. Portions of the structures are
not shown to improve clarity.
(C) The active site region of VRK3 compared with
that of VRK2, labeled as in panel B.
features that would hinder ATP binding
in VRK3 (Figure 2B). The G-loop forms
steric clashes with ATP at Q177VRK3 and
the surrounding backbone. The analo-
gous position in CK1 (S22CK1) instead
hydrogen bonds to the phosphate,
contributing to ATP binding. Interestingly,
D175VRK3 occupies the ATP binding site,
mimicking an ATP phosphate in an ATP
bound state. These and other changes produce a highly acidic
ATP binding pocket that is likely to repel rather than accept
the negatively charged phosphates of ATP (Figure 3). Neither
D175VRK3 nor Q177VRK3 is well conserved (Figure 2A), but the
acidic and bulky residue substitutions at these positions in VRK3
orthologs imply inhibition of ATP binding in all VRK3s.
Other changes to the ATP binding pocket occur outside of the
G-loop. D86CK1 and L88CK1 (in the interlobe linker) hydrogen
bond with the adenine ring of ATP (Figure 2B). D86CK1 accepts
a hydrogen bond from ATP via its backbone carbonyl; in VRK3
the equivalent proline (P260VRK3) has an altered backbone
conformation and can no longer bind ATP. L88CK1 donates a
hydrogen bond to ATP via its backbone amine, but in VRK3,
L262VRK3 has shifted conformation such that the side chain would
sterically clash with the adenine ring. The backbone hydrogen
bond of L262 is instead accepted by the side chain of S201VRK3
from b3, a very unusual substitution to a position that is always
hydrophobic (Figure 2A). Further, VRK3 has a conserved sub-
stitution to a large hydrophobic residue at F313VRK3 in b7 of the
C-terminal lobe, a position that is conserved as a smaller hydro-
phobic residue in active VRKs and CK1s (Figure S1, not shown in
Figure 2). The combined affect of these changes is to fill in much
of the region where the adenine ring would normally bind. The130 Structure 17, 128–138, January 14, 2009 ª2009 Elsevier Ltd All rights reserved
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Structure of the Pseudokinase VRK3changes also complete a conserved hydrophobic spine seen in
all protein kinases that is normally completed by the adenine
ring (Kornev et al., 2008), likely allowing VRK3 to be highly stable
in the absence of ATP. Taken together, the substantial array of
alterations to the ATP binding pocket of VRK3 strongly suggest
that it is nonfunctional, and that the structure has evolved adap-
tations to compensate for the loss of ATP binding.
VRK3 Does Not Bind ATP or ATP Analogs
We tested the degeneration of the ATP binding pocket by assay-
ing the ability of VRK3 to bind ATP or ATP-analog inhibitors. Puri-
fied VRK1, VRK2, and VRK3 proteins were screened against ATP
(plus divalent cations) and a kinase-directed library of 605 low-
molecular-weight potential inhibitors by monitoring changes in
protein melting temperature during thermal denaturation (Lo
et al., 2004). This method ranks inhibitors based on an observed
shift in melting temperature (Tm), which has been shown to corre-
late well with the binding strength and IC50 values (Bullock et al.,
2005). Although VRK1 and VRK2 bound ATP (Figure 3D), as well
as several inhibitors (Tables S3 and S4), VRK3 bound neither,
confirming that the ATP binding site in VRK3 is nonfunctional.
Figure 3. The Nonfunctional ATP Binding
Pocket of VRK3
(A) Electrostatic surface view of VRK2. The ATP
molecule (ball-and-sticks view) is modeled from
CK1.
(B) Equivalent view of VRK3 shows highly acidic
binding pocket and partial occlusion of modeled
ATP.
(C) Secondary structure representation of VRK2
showing the orientation of electrostatic represen-
tations.
(D) ATP binding capability of the VRKs, from
a thermal denaturation assay. DTm is the shift in
melting temperature when purified protein is
placed in solution with ligand, and is the average
of three experimental measurements (see Experi-
mental Procedures).
VRK3 was also screened against ATP
only (without divalent cations), and was
found to also not bind in these conditions
(data not shown). In support of the notion
that VRK3 is rigid and stable in the
absence of ATP, it had the highest native
Tm of the three proteins: melting temper-
atures were 49.8C, 47.5C, and 45.8C
for VRK3, VRK2, and VRK1, respectively.
Most Pseudokinases Have
Degraded G-Loop Motifs
The lack of ATP binding in VRK3 sug-
gested that degradation of the G-loop
motif might serve as an independent
predictor of kinase inactivity, beyond the
motifs previously used. We examined
this motif in all human kinase domains
(Manning et al., 2002b). Almost all active
kinases retained the basic GxGxxG motif,
whereas a few had conservative substitutions to the first and
third glycines, resulting in a generalized motif of (G/S/
A)xGxx(G/S/A). Only 16 active kinase domains violate this motif
(4%), including the four WNKs, which have a known active
site modification that changes the motif (Min et al., 2004)
(Table 1). However, 41 of the 49 current predicted pseudokinase
domains (84%) violate the motif, and 28 have severe motif
changes, often replacing glycines with acidic residues, as seen
in VRK3 (Table S5). This indicates that most pseudokinases
have divergent G-loops, and probably either cannot bind ATP
or cannot properly orient it for catalysis. Remarkably, CASK
and Titin, which have modifications to another key motif yet
retain catalytic activity (Mukherjee et al., 2008; Takano-Ohmuro
et al., 1992), do not violate the G-loop motif (Table 1).
Examination of the VRK3 structure revealed another important
predictor of kinase activity: A39CK1 in b3 forms part of the
adenine binding pocket and is replaced by S201 in human and
many other VRK3s, as described above (Figures 2A and 2B).
Most active protein kinases contain an alanine here, often as
part of a VAIK motif (Table S5), though other small hydrophobic
residues (V/I/L/M) are also acceptable (valine is seen in activeStructure 17, 128–138, January 14, 2009 ª2009 Elsevier Ltd All rights reserved 131
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Structure of the Pseudokinase VRK3Table 1. Key Motifs from Human Sequences of Unconventional Active Kinases, Selected Pseudokinases, and Pseudokinases
with Moderate Deficits
Kinase G-Loop G-Loop Status b3 hrD DfG Notes
Unconventional Active Kinases
CASK GKGPFS I FAVK HRD GFG Active, compensation for missing DfG is unknown
(Mukherjee et al., 2008)
WNK1 GRGSFK P VAWC HRD DLG Active, K in G-loop compensates for missing K in b3
(Min et al., 2004)
Titin GRGEFG I YMAK HFD EFG Active, structure shows that E of EFG functionally
replaces D (Mayans et al., 1998)
Selected Pseudokinases
VRK3 TRDNQG D FSLK HGN GFG Experimentally inactive (Nichols and Traktman, 2004),
cannot bind ATP
HSER (GC-C) RRDTIQa D VILK HGR DFG Binds ATP despite highly degraded G-loop motif,
experimentally inactive (Jaleel et al., 2006)
STRAD (STLK5) GKGFED P VTVR HRS GLR Binds ATP despite moderate degradation in G-loop
and substitution in b3, experimentally inactive
(Boudeau et al., 2004)
ILK NENHSG D IVVK RHA DVK Experimentally inactive (Boudeau et al., 2006)
EphB6 GTGSFG I VAIQ HRS RLG Experimentally inactive (Gurniak and Berg, 1996)
HER3 (ErbB3) GSGVFG I VCIK HRN DFG Experimentally inactive, reversion of HRN to HRD fails
to reactivate (Prigent and Gullick, 1994)
Pseudokinases with Moderate Deficits
RYK QEGTFG P AFVK HKD DNA Experimentally inactive, reversion of DNA to DFG
reactivates (Katso et al., 1999)
KSR1 GQGRWG I VAIR HKD DFG Experimentally inactive (Kolch, 2005; Morrison, 2001)
KSR2 GKGRFG I VAIR HKD DFG Experimentally inactive (Kolch, 2005; Morrison, 2001)
CCK4 GKSEFG P VLVK HKD ALG Experimentally inactive, repair of altered DfG motif in
Hydra ortholog fails to reactivate (Kroiher et al., 2001)
SuRTK106 CSGSCG P VILK HGD GLG
IRAK3 (IRAK-M) GEGEIF P YAVK CGS DFA Experimentally inactive (Wesche et al., 1999)
JAK1 Dom2 GRGTRT P VILK HGN DPG
JAK2 Dom2 GQGTFT P VLLK HGN DPG
JAK3 Dom2 GHGSFT P VLLK HGN DPG
TYK2 Dom2 GQGTRT P VVLK HGN DPG
SgK071 NPGALG P HVIK HRN DLS
PSKH2 GTGSFS I FAIK HRN DFG
Key residues are in bold when conserved and underlined when not conserved. G-loop status scores conservation of GxGxxG motif: I indicates intact,
conforms to consensus; p, plausible, with conservative changes; D, degraded, severe changes. Pseudokinases with moderate deficits have a G-loop
motif that is either intact or plausible, and no more than one other defect in other motifs. See Table S5 for data on all pseudokinases.
a Motif is a best estimate, because we were unable to align this region to active kinases with confidence.VRKs, Figure 2A). However, 16 pseudokinases (33%) have
unusual substitutions, and 10 of these are serine or threonine resi-
dues (Table S5), which would be capable of forming a similar inter-
action to that of S201 in VRK3 (Figure 2B, see above). Unlike the
G-loop motif, no active kinase violates the expanded consensus
motif for this position. Thus, whereas this marker is less sensitive,
it appears to be highly specific.
Using these additionalmotifs,andunconventionalactivekinases
(WNKs, Titin, and CASK) as a guideline, we looked for pseudoki-
nase sequences that have similarly moderate deficits, and thus
could possibly retain cryptic activity. This survey revealed 12 pseu-
dokinases thathad an intact G-loopmotif (or one thatwas plausibly
compatible with activity, as in the WNKs) and only one other deficit
in the four other motifs, as seen in all the unconventional kinases132 Structure 17, 128–138, January 14, 2009 ª2009 Elsevier Ltd All(Table 1). All other pseudokinases had highly degraded G-loop
motifs and/or more degradation of other key motifs (Table S5),
further supporting predictions of their inactivity.
Key Catalytic Motifs in VRK3 Retain Structural,
but Not Functional, Residues
In addition to loss of ATP binding, the distinctive kinase catalytic
motifs are also degraded in VRK3 (Figures 2A and 2C). The
aspartate in the catalytic loop hrDxkxxN (D166VRK2), which
orients the hydroxyl group of the substrate residue (Madhusudan
et al., 2002) and is essential for catalytic activity (Gibbs and
Zoller, 1991), is replaced by an asparagine in human VRK3
(N306) and in 50% of VRK3 orthologs. VRK3 has also
completely lost the neighboring conserved lysine (K168VRK2,rights reserved
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Structure of the Pseudokinase VRK3T308VRK3), which forms key interactions in the active site, and is
thought to be important in the catalytic mechanism (Bossemeyer
et al., 1993; Madhusudan et al., 2002). Finally, the aspartate in
the metal-binding DfG motif (D186VRK2), conserved in virtually
all active kinases, is lost in VRK3, indicating limitations in ATP
stabilization and phosphotransfer.
By contrast, residues that also play a structural role in stabi-
lizing the kinase conformation, such as the K203-E214VRK3 ion
pair (K72-E91PKA), have been retained. Likewise, both H304
and N311VRK3 of the hrDxkxxNmotif are retained; these stabilize
the active site conformation by hydrogen bonding to the back-
bones of A325 and N306VRK3, respectively (Figures 2A and
2C). As a result, the active site conformations of VRK3 and
VRK2 are very similar, despite the inactivity of VRK3 (Figure 2C).
The Activation Segment of VRK3 Is Distinct
from that of Active VRKs
The activation segment of protein kinases runs from the DfG
motif (DyG in VRKs) to an APE motif (SxN in most CK1 group
kinases, SxD in VRKs) (Nolen et al., 2004). Between these two
motifs are an activation loop, which activates many kinases
when phosphorylated, and a p+1 loop, which is important in
substrate binding (Figure 4A). The activation segments of
VRK2 and VRK3 are well defined and adopt a surprisingly similar
conformation, though there are changes in VRK3 that might
result from its catalytic inactivity (Figures 4B and 4C).
VRK3 retains the central tyrosine in the DyG motif, and partially
conserves the glycine, but replaces the essential aspartate with
a conserved G326VRK3 (Figure 4A). By contrast, it retains the SxD
motif at the end of the loop, probably due to its structural role in
anchoring the loop and stabilizing the C-terminal subunit (Nolen
et al., 2004; Scheeff and Bourne, 2005). The sequence of the rest
of the VRK3 activation segment is also largely conserved and
similar to that of active VRKs, correlating with the observed
structural similarity and suggesting a retained functional role.
However, toward the end of the activation loop, where all
VRKs have an insert relative to CK1, the sequences and struc-
tures of VRK2 and VRK3 diverge (Figure 4). In VRK2, residues
206–208 form a short 3-10 helix, with the charged R207 facing
out to the solvent, opening a groove through the middle of the
activation loop that might participate in substrate binding
(Figure 4B). In VRK3, this helix is replaced by a kink, in which
the equivalent basic residue (R347) flips inward, partly filling in
the middle of the loop region and forming a cation-p interaction
with a conserved aromatic residue at F331VRK3. This VRK3-
specific change might further stabilize the activation segment,
perhaps simultaneously occluding a region that would otherwise
bind substrate in an active VRK. Second, a cluster of 3 residues
(R210, F329, E351VRK3) come together to directly block part of
the interaction surface of the p+1 loop and so occlude part of
the potential substrate binding region immediately adjacent to
(what would otherwise be) the catalytic center of the enzyme.
The interactions between these residues also form a bridge
that links the N-terminal and the C-terminal lobes, likely further
stabilizing VRK3 in a closed pseudo-active conformation (Fig-
ure 4C). Finally, all active VRKs conserve two threonines (T213,
T217VRK2) in the p+1 loop that are lost in VRK3 (Figure 4A).
T213 is found in most serine/threonine kinases, anchoring the
loop and organizing the active site via hydrogen bonds toStructure 17, 12D166 and K168VRK2 in the hrDxkxxN catalytic loop motif (Nolen
et al., 2004) (Figure 4B). Neither of these interacting residues is
conserved in VRK3 (Figure 4C). T217VRK2 forms a hydrogen
bond to the backbone of N211VRK2 to help stabilize the position
of the activation segment (Figure 4B), and thus its loss in VRK3
Figure 4. Changes in the VRK3 Activation Segment
(A) Sequence conservation logos for the full activation segments of VRK3s,
active VRKs, and the CK1 family, based on appropriate subsets of a curated
sequence/structure alignment of diverse homologs (see Experimental Proce-
dures), labeled with same conventions as Figure 2A. Subsections of the acti-
vation segment are shown below the motifs.
(B) The activation segment of VRK2, shown in cyan, with 3–10 helices in violet
and structure outside of the activation segment in gray. Residues are shown
with same conventions as Figures 2B and 2C. Portions of the structure are
not shown to improve clarity.
(C) VRK3 activation segment, labeled as in panel B.8–138, January 14, 2009 ª2009 Elsevier Ltd All rights reserved 133
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Structure of the Pseudokinase VRK3Figure 5. Surface Conservation Patterns for VRK3s Only, All VRKs, and CK1s
(A) View of the face of the molecules opposing the active site. The top three of nine conservation bins from ConSurf (see Experimental Procedures) are shown in
corresponding shades of blue (darkest blue indicates the most conserved). Results for all VRKs are mapped onto the VRK3 structure, but are valid for all family
members. Results for CK1s are mapped onto the CK1 structure. Conservation scoring is scaled to each sequence grouping, and is not directly comparable
between groups. The unique conserved patch present in VRKs, but not CK1s, is circled.
(B) Molecules from panel A are rotated 120 such that the active site and substrate binding region is facing forward.may reflect the change in conformation of this segment.
Although the structural differences seen between VRK3 and
VRK2 could simply represent alternate conformations that occur
in both structures, this is unlikely: the structural changes coin-
cide with distinct sequence changes in VRK3 that violate the
evolutionary constraints in the active VRKs (Figure 4), indicating
that they are the likely cause of the structural reorganization.
These changes might eliminate substrate binding in VRK3,
though relatively little is known about substrate interaction by
CK1 group kinases (Longenecker et al., 1996; Nolen et al.,
2004; Xu et al., 1995), and it is possible that VRK3 still uses
this modified region in interactions with other proteins.
VRK3 Displays an Inverted Pattern of Surface
Conservation, Suggesting that the Back
of the Enzyme Forms Key Functional Interactions
The lack of ATP binding and catalytic activity, coupled with the
surprisingly conserved fold of VRK3, suggested that the VRK3134 Structure 17, 128–138, January 14, 2009 ª2009 Elsevier Ltd Allstructure might be maintained to provide a binding surface for
other proteins, a known function of many pseudokinases (Bou-
deau et al., 2006). VRK3 has been shown to bind and activate
the phosphatase VHR (Kang and Kim, 2006), so we sought to
investigate the structural basis of this (and other possible) inter-
actions. Using curated homologous sequences from a wide
range of organisms, we searched for selectively conserved
patches of surface residues. We compared VRK3 orthologs
with active VRKs and with CK1 family kinases, mapping residue
conservation to the relevant structures using ConSurf (Landau
et al., 2005). This revealed a large patch of highly conserved resi-
dues on the face of VRK3 opposite the active site, from aC, b4,
and b5, and the activation segment (Figure 5A). This patch is in
contrast to the active site region of VRK3, which has a poorly
conserved surface (Figure 5B), consistent with an inactive
enzyme. A subset of the VRK3 patch (with residues from aC,
b4, and b5) is conserved in all VRKs, but not in the CK1 family,
suggesting that the patch mediates a VRK-specific functionrights reserved
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Structure of the Pseudokinase VRK3that has been further adapted in VRK3 (Figures 5A and 6). Within
this smaller patch, we found a highly conserved flanking region
consisting of 4 pan-VRK residues, of which 3 are basic,
surrounding a core that includes 4 residues that are conserved
but distinct between VRK3 and VRK1/2 (Figure 6). This pattern
suggested that the flanking region might present a general
protein interaction site, whereas the core provides binding spec-
ificity between VRK3 and VRK1/2. Examination of the core
revealed that, remarkably, viral VRKs display a pattern that is
most similar to VRK3, suggesting that viral VRKs might have
evolved to form a similar interaction to VRK3, despite being
active enzymes (Figure 6B).
DISCUSSION
The twin structures of VRK2 and VRK3 provide the first insights
into the structural consequences of loss of catalytic activity in
a pseudokinase. They also enable a deeper understanding of
the remaining regulatory functions that have been proposed for
many pseudokinases (Boudeau et al., 2006). Surprisingly, the
overall fold is highly conserved between the two structures,
contrary to expectations from sequence alignment that the
VRK3 structure would be degraded. This strong constraint on
structure, relative to lossof overall sequence constraints, is further
seen in the key kinase motifs, where residues that have structural
roles are largely conserved whereas neighboring catalytic resi-
dues are lost. Along with the rigidity of the activation segment
and G-loop, these observations suggest that VRK3 might have
been retained as a scaffold or regulatory binding partner.
One clue to the structural conservation of VRK3 is the
conserved patch opposite the active site. Several structural
elements contribute to the patch, and are likely to be constrained
by this function. The patch was not obvious from the linear
sequence alone, and required a combination of the crystal struc-
ture and prediction of orthologous sequences to be identified.
The observed conservation pattern (Figure 6) suggests that
Figure 6. Putative Binding Site on the Back of VRK3
(A) Key residues of the putative binding patch, mapped to a surface view of
VRK3. Red residues are conserved in all VRKs, and blue are conserved but
with distinctive patterns in VRK3 versus VRK1/2.
(B) Motif logos of site in different VRKs and the CK1 family. Sequence is a cate-
nation of residues distributed within the sequence alignment: residues in the
VRK3 structure are numbered above the alignment, and black bars indicate
break points where intervening sequence was removed. The two subsets of
conserved residues are indicated above the motifs.Structure 17, 1VRK3 uses the patch for a distinct function that cannot be repli-
cated by another VRK, perhaps for its unique capability among
vertebrate VRKs to interact with and activate VHR (Kang and
Kim, 2006, 2008). Because VHR and VRK3 are both vertebrate
specific, and all VRK3 orthologs are predicted to be inactive, it
is likely that VRK3 regulation of VHR emerged early in vertebrate
evolution from a pre-existing interaction site, allowing VRK3 to
be retained even in the absence of any catalytic function. The
patch motif in viral VRKs is most similar to that of VRK3 (Figure 6),
raising the intriguing possibility that viral VRKs, though active
kinases, might have evolved to bind the same partner as
VRK3, and perhaps interfere with VRK3-mediated regulation.
VRK3 might bind other partners, perhaps acting as a scaffold
to integrate multiple signals in regulation of VHR. This sort of
scaffolding role has been seen in other pseudokinases (Boudeau
et al., 2006) and in the noncatalytic C terminus of VRK2. Addi-
tional interactions could provide an alternate explanation for
the observed patch, along with the other smaller regions of
conservation seen on the surface of VRK3 (Figure 5), and several
studies have indicated that such interactions occur. Incubation
of VRK3 with HT22 cell lysate results in phosphorylation of
VRK3 and copurification of a kinase activity, suggesting that it
might bind to and be phosphorylated by an active kinase (Kang
and Kim, 2006). Disruption of the K203-E214 ion pair (K72-
E91PKA) abolished this phosphorylation, confirming that the
structural integrity of VRK3 is required for this interaction. Erk,
VHR, and VRK3 coimmunoprecipitate as a ternary complex,
and it has been suggested that VRK3 provides an Erk interaction
site for VHR, because VHR lacks the MAPK binding domain
found in most other MAPK phosphatases (Kang and Kim,
2008). A recent report shows that the small nuclear GTPase,
Ran, is another VRK3 binding partner and also binds and catalyt-
ically inhibits VRK1 and VRK2 (Sanz-Garcia et al., 2008).
The VRK3 structure also highlights the importance of the
G-loop and b3 motif in ATP binding and kinase activity. Muta-
tions to the G-loop motif have a drastic effect on the catalytic effi-
ciency in active kinases (Grant et al., 1998). The G-loop motif
degeneration in VRK3 corroborates the loss of ATP binding
shown by thermal denaturation assay. Loss of the motif corre-
lates well with loss of catalytic residues in other pseudokinases
(Manning et al., 2002b), and helps to refine these predictions
(Table S5). For example, both Titin and CASK were predicted
to be pseudokinases based on loss of the DFG aspartate, but
both retain the G-loop and b3 motifs, and this correlates with
their observed catalytic activities (Mukherjee et al., 2008;
Takano-Ohmuro et al., 1992) (Table 1). Conversely, Ryk retains
the 3 main catalytic residues but lacks the consensus G-loop
and b3 motifs, and has convincingly been shown to be catalyti-
cally inactive (Katso et al., 1999) (Table 1). However, these addi-
tional motifs are not completely predictive: a few active kinases
also lack the consensus G-loop motif (Table S5), and some pseu-
dokinases (such as STRADs and guanylyl cyclases) bind ATP
despite deficits in one of the two motifs (Table 1), and might
require it for (noncatalytic) function (Boudeau et al., 2004; Jaleel
et al., 2006). By combining all motif data, we detected 12 pseu-
dokinases that would the most likely to be cryptically active,
because of mild modifications to the G-loop motif, coupled to
loss of only one of the other key motifs (Table 1). However, there
are reasons to believe that activity in many of these proteins is28–138, January 14, 2009 ª2009 Elsevier Ltd All rights reserved 135
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hrD motif, a position that is thought to be essential to activity
(Gibbs and Zoller, 1991), and many have been found to be inac-
tive in experiments (Table 1). Still, there are examples of loss of
the hrD motif in distantly related microbial kinases (Kannan
et al., 2007) and, as with CASK (Mukherjee et al., 2008), it is
possible that some pseudokinases could be active only in
unusual conditions. Thus, although 49 pseudokinase domains
are predicted to be inactive like VRK3, a few might hold surprises.
It remains to be seen how predictive the structural features
seen in VRK3 will be for other pseudokinases. Unlike active
kinases, which are constrained in evolution by a shared catalytic
activity, each pseudokinase faces a distinct set of evolutionary
pressures dictated by its unique remaining functions. Indeed,
this pattern is reflected in their varied patterns of motif degrada-
tion (Table S5). However, the strong structural similarity between
VRK3 and VRK2 suggests that the 25 human pseudokinases
with severe sequence degeneration (Manning et al., 2002b)
might still produce a highly conserved fold. Such fold conserva-
tion makes evolutionary sense: a pseudokinase ancestor would
almost certainly ‘‘learn’’ its noncatalytic interactions while still an
active kinase. Once catalytic activity was lost, maintaining these
interactions could require the pseudokinase to mimic the surface
of its active ancestor. Thus, the result would likely be a pseudo-
kinase with a conserved structure, as seen in VRK3. Because
other pseudokinases also participate in multiple protein-protein
interactions (Boudeau et al., 2006), it is likely that most will
look very much like active kinases, despite their catalytic deficits.
Addressing themysteryofVRK3functionbenefited froma close
integration of structural analysis and comparative genomics. The
complexity of the evolutionary pressures on pseudokinases
argues for the use of such a combined approach, because it
allows observed structural features to be placed in evolutionary
context. In VRK3, the combination was able to distinguish motif
residues involved in functional versus structural roles, identify
conservation patches built from multiple distinct sequence
regions, and highlight the remaining constraints on this important
‘‘dead’’ kinase. We anticipate that, as here, the fusion of genomics
and structural genomics will soon provide more insight into the
retained features and functions of other pseudokinase domains.
EXPERIMENTAL PROCEDURES
Cloning of Structural Sequences
Catalytic domain residues were amplified from cDNA provided by FivePrime.
VRK1 (residues 1–365), VRK2 (15–335), and VRK3 (14–-472) were cloned
into the vector, pNIC-SGC, by ligation-independent cloning (Stols et al.,
2002). The vector includes a TEV-cleavable (*) N-terminal His6 tag
(MHHHHHHSSGVDLGTENLYFQ*SM). The TEV cleavage site is present in
the structure of VRK3 (positions 137–145) and generates an a helix from posi-
tions 138–147 (omitted from all figures).
Expression and Purification
Transformed BL21(DE3) cells were grown in Luria-Bertani medium containing
50 mg/ml kanamycin. Protein expression was induced at an OD600 of 0.8 using
1 mM isopropyl-thio-galactopyranoside (IPTG) at 20C for 12 hr. Cells
expressing VRK2 or VRK3 were lysed in 50 mM HEPES (pH 7.5), 500 mM
NaCl, 1 mM PMSF, and 0.5 mM TCEP using an EmulsiFlex high-pressure
homogenizer. After centrifugation, the supernatant was loaded onto a
Nickel-Sepharose column equilibrated in 30 ml binding buffer (50 mM HEPES
[pH 7.5], 500 mM NaCl, 5 mM imidazole, 0.5 mM TCEP, and 5% glycerol). The136 Structure 17, 128–138, January 14, 2009 ª2009 Elsevier Ltd Allcolumn was washed with 3 3 10 ml wash buffer (loading buffer with 30 mM
Imidazole). Proteins were eluted by an imidazole step gradient and applied
to a Superdex 200 16/60 gel-filtration column equilibrated in 50 mM HEPES
(pH 7.5), 150 mM NaCl, and 5 mM DTT.
Crystallization
Crystallization was performed using sitting drops, mixing protein (8–10 mg/ml)
and well solutions in 2:1, 1:1 and 1:2 ratios. VRK3 apocrystals were obtained
using a well solution containing 0.1 M HEPES (pH 7.5) and 2 M ammonium
formate at 4C. VRK2 was crystallized using 0.1 M Na(succ) and 15% PEG
3350 at 20C.
Data Collection and Processing
Crystals were cryoprotected using the well solution supplemented with an
additional 20% ethylene glycol and flash frozen in liquid nitrogen. Diffraction
data were collected on the PXII beamline at the Swiss Light Source at 1.00
and 1.03 A˚ wavelengths for VRK2 and VRK3, respectively. Data were pro-
cessed using XDS. Multiple segments were scaled together using XSCALE
(Kabsch, 2001).
Structure Solution, Model Building, and Refinement
VRK3 was solved using an ensemble of CK1 structures (Protein Data Bank
[PDB] codes 2CMW, 2C47, 2IZR, 2IZS, 2IZT, 2IZU, 2CHL, 1CKI, and 1CKJ).
NCS-averaging was used to improve initial maps, and ARP/wARP was used
to produce an initial trace. The resulting map was clear enough to allow manual
model completion. Alternating cycles of refinement using REFMAC5 and
manual editing in Coot (Emsley and Cowtan, 2004) were performed until con-
vergence.VRK2 was solved using VRK3 as a search model. The initial map was
improved using ARP/wARP, followed by NCS-averaging, after which the struc-
ture could be autobuilt using ARP/wARP and refined using alternating cycles of
REFMAC5 and Coot.
Structure Alignment and Analysis
All structural coordinates were collected from the PDB, and processed
through MolProbity (Davis et al., 2007) to add optimized hydrogen atoms. All
Asn/Gln/His residue flips suggested by MolProbity were also applied. Struc-
tures were aligned and superimposed using DaliLite (Holm and Park, 2000).
Published structures included CK1 (1CSN) (Xu et al., 1995), Sky1p (1Q97) (No-
len et al., 2003), and PKA (1CDK) (Bossemeyer et al., 1993). In all cases, chain
A from the PDB file was used, with the exception of VRK3, in which chain B was
used. For the electrostatic models (Figure 3), the missing G-loop in VRK2 (resi-
dues G36-G41) was modeled in Coot (Emsley and Cowtan, 2004) and further
optimized in ICM (Molsoft L.L.C., La Jolla, CA). The electrostatic surfaces for
VRK3 and VRK2 were then calculated using ICM.
Sequence Prediction and Alignment
To measure the evolutionary constraints on vertebrate VRKs, we predicted
VRK sequences for a wide range of vertebrates: five fishes, six mammals,
chicken, and frog, and from a range of invertebrate metazoans and viruses,
using Gene Detective (Time Logic, Carlsbad, CA) and GeneWise (Birney
et al., 2004) predictions, and Ensembl (Hubbard et al., 2007) and GenBank
(Benson et al., 2008) protein and EST sequences. Predicted sequences were
manually curated. VRK and CK1 sequences were aligned using muscle (Edgar,
2004), followed by manual editing, with the help of structure-based sequence
alignments from DaliLite (Holm and Park, 2000) (Figure S1). All sequences are
available at http://kinase.com.
Surface Conservation and Motif Analysis
Surface conservation was measured using the ConSurf server, with the default
(Bayesian) method (Landau et al., 2005). The appropriate subsets of the above
curated alignment were used as the sequence inputs to the ConSurf algorithm
for each family. Logos were generated with the WebLogo server (Crooks et al.,
2004).
Thermal Stability Assay for ATP, Inhibitor, and Cation Binding
Proteins were assayed for shifts in melting temperature caused by presence of
MgCl2 or MnCl2 (2.5 mM), ATP (5 mM), or ATP-mimetic kinase inhibitors
(10 mM). Thermal melting experiments were done using a Mx3005p RT-PCRrights reserved
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Structure of the Pseudokinase VRK3machine (Stratagene). The purified VRK1, VRK2, and VRK3 proteins were buff-
ered in 10 mM HEPES (pH 7.5) and 150 mM NaCl and assayed in a 96-well
plate at a final concentration of 5 mM in 20 ml volume. SYPRO-Orange (Molec-
ular Probes) was added as a fluorescence probe at a dilution of 1 in 1000. Exci-
tation and emission filters for the SYPRO-Orange dye were set to 465 and 590
nm, respectively. The temperature was raised with a step of 1C per minute
from 25C to 96C and fluorescence readings were taken at each interval.
The temperature dependence of the fluorescence during the protein denatur-
ation process was approximated by the equation
yðTÞ= yF + yU  yF
1+ eDuGðTÞ=RT
where DuG is the difference in unfolding free energy between the folded and
unfolded state, R is the gas constant and yF and yU are the fluorescence inten-
sity of the probe in the presence of completely folded and unfolded protein,
respectively (Matulis et al., 2005). The baselines of the denatured and native
state were approximated by a linear fit. The observed temperature shifts,
DTm
obs, for each inhibitor were recorded as the difference between the transi-
tion midpoints of sample and reference wells containing protein without inhib-
itor in the same plate and determined by nonlinear least-squares fit. Each Tm
value given (Figure 3D) is an average of three experimental measurements.
Values given for native Tm in the text are an average of five experimental
measurements.
ACCESSION NUMBERS
The structure and corresponding structure factors for VRK2 and VRK3 were
deposited in the Protein Data Bank under accession numbers 2V62 and 2JII,
respectively (Table S1).
SUPPLEMENTAL DATA
Supplemental Data include five tables and one figure and can be found
with this article online at http://www.cell.com/structure/supplemental/
S0969-2126(08)00427-9.
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